Cargando…
Development of an in vitro PIG-A gene mutation assay in human cells
Mutagens can be carcinogens, and traditionally, they have been identified in vitro using the Salmonella ‘Ames’ reverse mutation assay. However, prokaryotic DNA packaging, replication and repair systems are mechanistically very different to those in the humans we inevitably seek to protect. Therefore...
Autores principales: | Rees, Benjamin J, Tate, Matthew, Lynch, Anthony M, Thornton, Catherine A, Jenkins, Gareth J, Walmsley, Richard M, Johnson, George E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907909/ https://www.ncbi.nlm.nih.gov/pubmed/28057708 http://dx.doi.org/10.1093/mutage/gew059 |
Ejemplares similares
-
Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study
por: Nichols, Lucy, et al.
Publicado: (2023) -
Empirical comparison of genotoxic potency estimations: the in vitro DNA-damage ToxTracker endpoints versus the in vivo micronucleus assay
por: Wills, John W, et al.
Publicado: (2021) -
Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations
por: Conway, Gillian E, et al.
Publicado: (2020) -
Cytotoxicity and genotoxicity of urban particulate matter in mammalian cells
por: Dumax-Vorzet, Audrey F., et al.
Publicado: (2015) -
The clastogenicity of 4NQO is cell-type dependent and linked to cytotoxicity, length of exposure and p53 proficiency
por: Brüsehafer, Katja, et al.
Publicado: (2016)